Some 777 cases of ovarian cancer (OvC) and 1026 cases of uterine corpus cancer (UC) were compared with 3211 and 3668 matched controls for OvC and UC, respectively. The adjusted odds ratios for risk of cancer were 0.7 (0.6 -0.9) and 0.8 (0.7 -0.99) for OvC and UC for ever vs never...
Evaluation of publicly available in vitro drug sensitivity models for ovarian and uterine cancer Objective Publicly available data on drug sensitivity for cancer cell lines have been curated into a single, integrated database, PharmacoDB. The contributing datasets report modeled estimates of drug effect...
The ASR for ovarian and uterine cancers were 6.75 per 100 000 and 5.14 per 100 000, respectively. Over the study period, the incidence of these cancers was largely stable with no significant change in incidence rates recorded. In sum, the ASR for cervical cancer is relatively low compared ...
Now, researchers from the Cancer Dependency Map (DepMap) project at the Broad Institute of MIT and Harvard have identified a hidden vulnerability in ovarian and uterine cancers—as well as a way to exploit it that could inspire new, much-needed drugs for these cancers. A team led by institut...
and means to deliver therapies to the tumors. One therapeutic target is the protein AXL, which has been shown to be involved in metastasis in both ovarian and uterine cancer. An effective way to target AXL is to silence its expression with small interfering RNA (siRNA). We investigate the ...
Most uterine cancers have excellent five-year survival rates—up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer.
Instead, it merely outlines the development of my own point of view on the subject from the early work on the follicular hormone in which normal reactions were reproduced to work of more recent date indicating a possible role of this hormone in mammary and uterine cancer. Since the early ...
Gynecologic Cancer InterGroup (GOG) Consensus Review for Uterine and Ovarian Ca.rcinosarcoma Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma. Int J Gynecol Cancer 24, S55-S60. http://dx.doi.org/... D Berton-Rigaud,M Devouassoux-Shisheboran - 《...
Is the outcome of in-vitro fertilization and embryo transfer treatment improved by spontaneous or surgical drainage of a hydrosalpinx? A pilot study was designed to examine whether the outcome of embryo transfer in women with a hydrosalpinx might be improved by surgical drainage of the hyd... ...
Ovarian metastasis with cancer of the uterine body is transtubal implantation an important factor? Author links open overlay panel https://doi.org/10.1016/S0002-9378(15)30004-1Get rights and content Access through your organization Check access to the full text by signing in through your ...